×
Back to Agenda
Session 3. Unlocking Potential : A Status Check on Multi-Reginal Clinical Trials for Global Drug Development
Session Chair(s)
Edana Loke
Director, JAPAC Regulatory Policy and Intelligence
AbbVie Pte Ltd, Singapore, Singapore
Martin Lim, MBA, MS
Co-Founder and CEO
ONWARD Health Research, Singapore
Speaker(s)
Martin Lim, MBA, MS
ONWARD Health Research, Singapore
Co-Founder and CEO
Romi Singh, PhD
Northeastern University, United States
Professor of Practice, Regulatory Sciences
I-Chun Lai, MD, MS
Center for Drug Evaluation, Taiwan, Taiwan
Senior Director, Division of Consultation
Dona Arlinda
Ministry of Health (MOH) Indonesia, Indonesia
Clinical Research Manager, INA-CRC
Bindoo Chahal, RPh
AbbVie Pte. Ltd., Singapore
JAPAC Regulatory Affairs, Therapeutic Area Head
Indri Rooslamiati Supriadi
Indonesia Ministry of Health (MOH), Indonesia
Head of BB Binomika (Parent Organization of INA-CRC)
Have an account?